177 related articles for article (PubMed ID: 21120693)
21. The pattern of beta-catenin responsiveness within the mammary gland is regulated by progesterone receptor.
Hiremath M; Lydon JP; Cowin P
Development; 2007 Oct; 134(20):3703-12. PubMed ID: 17881490
[TBL] [Abstract][Full Text] [Related]
22. The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse.
Fernandez-Valdivia R; Mukherjee A; Ying Y; Li J; Paquet M; DeMayo FJ; Lydon JP
Dev Biol; 2009 Apr; 328(1):127-39. PubMed ID: 19298785
[TBL] [Abstract][Full Text] [Related]
23. Corneal morphogenesis during development and diseases.
Kao WW
Eye Contact Lens; 2010 Sep; 36(5):265-8. PubMed ID: 20724850
[TBL] [Abstract][Full Text] [Related]
24. Stabilization of Epithelial β-Catenin Compromises Mammary Cell Fate Acquisition and Branching Morphogenesis.
Satta JP; Lan Q; Taketo MM; Mikkola ML
J Invest Dermatol; 2024 Jun; 144(6):1223-1237.e10. PubMed ID: 38159590
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Johnson AL; Zinser GM; Waltz SE
Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
[TBL] [Abstract][Full Text] [Related]
26. Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice.
Li B; Chi X; Song J; Tang Y; Du J; He X; Sun X; Bi Z; Wang Y; Zhan J; Zhang H
Sci China Life Sci; 2019 Feb; 62(2):225-234. PubMed ID: 30460471
[TBL] [Abstract][Full Text] [Related]
27. Genetic mechanisms in Apc-mediated mammary tumorigenesis.
Kuraguchi M; Ohene-Baah NY; Sonkin D; Bronson RT; Kucherlapati R
PLoS Genet; 2009 Feb; 5(2):e1000367. PubMed ID: 19197353
[TBL] [Abstract][Full Text] [Related]
28. A beta-catenin survival signal is required for normal lobular development in the mammary gland.
Tepera SB; McCrea PD; Rosen JM
J Cell Sci; 2003 Mar; 116(Pt 6):1137-49. PubMed ID: 12584256
[TBL] [Abstract][Full Text] [Related]
29. A mouse model engineered to conditionally express the progesterone receptor-B isoform.
Hai L; Szwarc MM; Wetendorf M; Wu SP; Peavey MC; Grimm SL; Edwards DP; DeMayo FJ; Lydon JP
Genesis; 2018 Aug; 56(8):e23223. PubMed ID: 30004627
[TBL] [Abstract][Full Text] [Related]
30. The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.
Wang A; Arantes S; Yan L; Kiguchi K; McArthur MJ; Sahin A; Thames HD; Aldaz CM; Macleod MC
BMC Cancer; 2008 Sep; 8():268. PubMed ID: 18808719
[TBL] [Abstract][Full Text] [Related]
31. Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice.
Chikama T; Hayashi Y; Liu CY; Terai N; Terai K; Kao CW; Wang L; Hayashi M; Nishida T; Sanford P; Doestchman T; Kao WW
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1966-72. PubMed ID: 15914610
[TBL] [Abstract][Full Text] [Related]
32. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.
Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L
Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461
[TBL] [Abstract][Full Text] [Related]
33. Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium.
Kiaris H; Politi K; Grimm LM; Szabolcs M; Fisher P; Efstratiadis A; Artavanis-Tsakonas S
Am J Pathol; 2004 Aug; 165(2):695-705. PubMed ID: 15277242
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of mammogenesis using a novel tetracycline-inducible mouse model and in vivo imaging.
Creamer BA; Triplett AA; Wagner KU
Genesis; 2009 Apr; 47(4):234-45. PubMed ID: 19208431
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
Hu C; Diévart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
37. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
[TBL] [Abstract][Full Text] [Related]
38. Development of mammary tumors by conditional expression of GLI1.
Fiaschi M; Rozell B; Bergström A; Toftgård R
Cancer Res; 2009 Jun; 69(11):4810-7. PubMed ID: 19458072
[TBL] [Abstract][Full Text] [Related]
39. Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors.
Yan L; Della Coletta L; Powell KL; Shen J; Thames H; Aldaz CM; MacLeod MC
PLoS One; 2011 Jan; 6(1):e16515. PubMed ID: 21304988
[TBL] [Abstract][Full Text] [Related]
40. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
